博拓生物: 杭州博拓生物科技股份有限公司章程

Group 1 - The company is named Hangzhou Biotest Biotech Co., Ltd., established as a joint-stock company based on the original Hangzhou Biotest Biotechnology Co., Ltd. [2][3] - The company was registered on July 27, 2021, and publicly issued 26.66667 million shares of ordinary stock, listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on September 8, 2021 [2][3]. - The registered capital of the company is RMB 106.66667 million [3]. Group 2 - The company's business purpose is to adhere to the corporate spirit of "integrity, diligence, innovation, and dedication," aiming to maximize shareholder interests and contribute to societal progress [4][5]. - The business scope includes technology services, medical device sales, and various electronic products, among others [5]. Group 3 - The company issues shares in the form of stocks, with each share having a par value of RMB 1 [7]. - The total number of shares issued by the company is 106.66667 million, all of which are ordinary shares [7]. Group 4 - The company is structured to ensure that shareholders have equal rights and obligations, with provisions for the transfer of shares and the issuance of new shares [9][10]. - The company can repurchase its shares under specific circumstances, such as reducing registered capital or merging with other companies [8][9]. Group 5 - The company has established a governance structure that includes a board of directors and a supervisory committee, ensuring compliance with legal and regulatory requirements [12][18]. - Shareholders have the right to participate in decision-making processes, including voting on significant corporate actions [12][20].